Skip to content

Web-based preventive group intervention for persons bereaved by suicide: A randomized control group trial

Web-based preventive group intervention for persons bereaved by suicide: A randomized control group trial - GROUP-CARE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014426
Enrollment
72
Registered
2018-04-12
Start date
2018-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

suicidality bereavement, grief

Interventions

Group 1: Treatment group: receives online group therapy immediately after registration, based on cognitive-behavioral principles (psychoeducation, cognitive restructuring, dealing with difficult emoti
Period: 12 weeks, once a week

Sponsors

Medical School Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: - experienced loss of the suicide of a close person - Men and women - Adults between 18 and 75 years - Access to the Internet - German language skills - signed consent form - Currently not in psychotherapy

Exclusion criteria

Exclusion criteria: 1) Acute Suicidality: Suicidality is assessed in the telephone interview using the Suicide Risk Assessment Interview (SRAI; Arnoldi, Van de Ven, Schrieken, & Lange, 2000; Knaevelsrud, 2005). If potential participants express acute suicidality, they will be excluded from the treatment. In addition, the "suicide item" of the Beck-Depression-Inventaroy (BDI-II; Hautzinger et al., 2006) is considered separately in the weekly after-session-measurements. The answer options of the item are: 1) I do not think about doing anything to me; 2) I sometimes think of suicide but would not do it; 3) I would like to kill myself; 4) I would kill myself if I had the opportunity. If participants indicate any other option than option 1), a telephone appointment will be arranged and a separate suicide screening will be conducted, which will check the concreteness and quality of the suicidal thoughts. 2) Increased Depressiveness: Participants who have a BDI-II score of > 35 are excluded from the treatment. 3) Psychotic Experience: Participants with a cut-off score > 13 in the Dutch Screening Device for Psychotic Disorder (SDPD; Knaevelsrud, 2005; Lange, Schrieken, Blankers, Van de Ven, & Slot, 2000) are excluded from the study. 4) Increased Alcohol, Drug, or Substance Use: Measured by the biographical questionnaire and the Structured Clinical Interview for DSM-IV Achse I (SKID-I; Wittchen, Zaudig, & Fydrich, 1997). 5) Persons already in psychotherapeutic treatment: Measured using the biographical questionnaire. 6) Borderline personality disorder and/or self-injurious behavior: Measured by the Structured Clinical Interview for DSM-IV Axis II (SKID-II; Wittchen et al., 1997) 7) Bipolar disorder: Measured by the SKID-I.

Design outcomes

Primary

MeasureTime frame
We expect a significant reduction in suicidality immediately after completion of the treatment, as well as three or six months later. The questionnaire is provided in an online survey. Measurements to assess suicidality: - Revised Aquired Capability of Suicide Scale (ACSS-FAD, Spangenberg et al., 2014) - Beck Depression Inventory (BDI-II, Hautzinger et al., 2006) - Beck Scale for Suicide Ideation (Beck, Steer, & Ranieri, 1988) - Revised Aquired Capability of Suicide Scale (ACSS-FAD, Spangenberg et al., 2016)

Secondary

MeasureTime frame
1) GENERAL PROCESS OF SYMPTOM ASSESSMENT There are several measurement points: T1 = initial diagnostics T2 = middle of therapy T3 = end of therapy T4 = follow-up examination after 3 months T5 = follow-up examination after 6 months 2) STATUS DIAGNOSIS The following questionnaire are collected in the initial diagnosis (T1): - Socio-demographic questions - Screening for Complex Posttraumatic Stress Disorder (SkPTBS, Dorr, Sack & Bengel, 2018) After the initial diagnosis (T1) a personal telephone interview is carried out. In this, the following instruments will be used - SKID-I: Major depression (Wittchen et al, 1997) - SKID-II: Borderline disorder (Wittchen et al., 1997) - Suicide Risk Assessment Interview (SRAI; Arnoldi et al., 2000; Knaevelsrud, 2005) - Suicide Behaviors Questionnaire Revised (Glaesmer et al., 2017; translated by Wagner et al., 2013) - Dutch Screening Device for Psychotic Disorders (SDPD, Lange et al., 2000, Knaevelsrud, 2005) 3) TARGET CRITERIA: ASSESSMENT DURING THE TREATMENT 3.1) CHANGES IN THE COURSE OF TREATMENT: Changes in the extent of general psychopathology, stigmatization experience, grief reaction, perception of social support and hopelessness: - Health questionnaire for patients, short form (PHQ, Löwe et al., 2002) - Berlin Social Support Scales (BSSS, Schwarzer & Schulz, 2000) - Stigma of Suicide and Suicide Survivor Scale (STOSASS, Scocco et al., 2012) - Grief Experience Questionnaire (GEQ; Bailley et al., 2000; Barrett & Scott Original, 1989) - Posttraumatic cognition inventory (PTCI; Müller et al., 2010, Foa et al., 1999, original translation by Ehlers & Boos, 2000) - Scales for Hopelessness (H-scales, Krampen, 1994) - Aquired Capability of Suicide Scale, Revised (ACSS-FAD, Spangenberg et al., 2014) - Inventory of Complicated Grief (ICG, Prigerson, Maciejewski et al., 1995, German translation by Lumbeck, Brandstätter, & Geissner, 2012) - Impact of Event Scale (IES, Maercker & Schützwohl, 1998) - Beck De

Countries

Germany

Contacts

Public ContactLaura Hofmann

MSB Medical School Berlin

laura.hofmann@medicalschool-berlin.de+49 30 / 76 68 37 5 -830

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026